Calamos Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.57M | Sell |
65,212
-2,171
| -3% | -$56.8K | 0.05% | 166 |
|
|
2026
Q1 | $1.89M | Buy |
67,383
+3,188
| +5% | +$84.9K | 0.07% | 148 |
|
|
2025
Q4 | $1.6M | Buy |
64,195
+703
| +1% | +$17.7K | 0.06% | 147 |
|
|
2025
Q3 | $1.62M | Sell |
63,492
-268
| -0.4% | -$6.62K | 0.06% | 147 |
|
|
2025
Q2 | $1.55M | Sell |
63,760
-1,361
| -2% | -$31.7K | 0.07% | 134 |
|
|
2025
Q1 | $1.65M | Buy |
65,121
+12,647
| +24% | +$331K | 0.08% | 112 |
|
|
2024
Q4 | $1.39M | Buy |
52,474
+469
| +0.9% | +$12.7K | 0.07% | 119 |
|
|
2024
Q3 | $1.51M | Sell |
52,005
-80
| -0.2% | -$2.33K | 0.08% | 121 |
|
|
2024
Q2 | $1.46M | Sell |
52,085
-2,885
| -5% | -$79.4K | 0.08% | 118 |
|
|
2024
Q1 | $1.53M | Buy |
54,970
+460
| +0.8% | +$12.8K | 0.09% | 117 |
|
|
2023
Q4 | $1.57M | Sell |
54,510
-9,760
| -15% | -$295K | 0.1% | 108 |
|
|
2023
Q3 | $2.13M | Sell |
64,270
-1,795
| -3% | -$63.5K | 0.16% | 90 |
|
|
2023
Q2 | $2.42M | Sell |
66,065
-1,285
| -2% | -$50K | 0.18% | 91 |
|
|
2023
Q1 | $2.75M | Sell |
67,350
-30
| -0% | -$1.3K | 0.22% | 85 |
|
|
2022
Q4 | $3.45M | Sell |
67,380
-608
| -0.9% | -$29.1K | 0.27% | 83 |
|
|
2022
Q3 | $2.98M | Sell |
67,988
-2,637
| -4% | -$128K | 0.26% | 80 |
|
|
2022
Q2 | $3.7M | Buy |
70,625
+4,956
| +8% | +$253K | 0.33% | 73 |
|
|
2022
Q1 | $3.4M | Buy |
65,669
+325
| +0.5% | +$16.9K | 0.25% | 85 |
|
|
2021
Q4 | $3.86M | Sell |
65,344
-1,106
| -2% | -$54.8K | 0.28% | 81 |
|
|
2021
Q3 | $2.86M | Sell |
66,450
-2,391
| -3% | -$106K | 0.23% | 86 |
|
|
2021
Q2 | $2.7M | Buy |
68,841
+1,766
| +3% | +$68.7K | 0.21% | 91 |
|
|
2021
Q1 | $2.43M | Sell |
67,075
-1,555
| -2% | -$55.2K | 0.2% | 91 |
|
|
2020
Q4 | $2.53M | Buy |
68,630
+39,437
| +135% | +$1.45M | 0.23% | 78 |
|
|
2020
Q3 | $1.02M | Sell |
29,193
-5,098
| -15% | -$179K | 0.12% | 125 |
|
|
2020
Q2 | $1.06M | Sell |
34,291
-10,152
| -23% | -$345K | 0.13% | 106 |
|
|
2020
Q1 | $1.38M | Sell |
44,443
-135,155
| -75% | -$4.61M | 0.21% | 73 |
|
|
2019
Q4 | $6.68M | Buy |
179,598
+643
| +0.4% | +$22.9K | 0.79% | 30 |
|
|
2019
Q3 | $6.1M | Buy |
178,955
+2,803
| +2% | +$102K | 0.82% | 31 |
|
|
2019
Q2 | $7.24M | Buy |
176,152
+2,117
| +1% | +$84.1K | 0.98% | 24 |
|
|
2019
Q1 | $7.01M | Buy |
174,035
+52,299
| +43% | +$2.09M | 1% | 21 |
|
|
2018
Q4 | $5.04M | Buy |
121,736
+3,935
| +3% | +$163K | 0.76% | 35 |
|
|
2018
Q3 | $4.93M | Buy |
117,801
+472
| +0.4% | +$18.2K | 0.61% | 51 |
|
|
2018
Q2 | $4.04M | Sell |
117,329
-3,106
| -3% | -$106K | 0.5% | 63 |
|
|
2018
Q1 | $4.06M | Buy |
120,435
+2,180
| +2% | +$74.9K | 0.51% | 66 |
|
|
2017
Q4 | $4.06M | Sell |
118,255
-2,332
| -2% | -$79.5K | 0.53% | 63 |
|
|
2017
Q3 | $4.08M | Buy |
120,587
+1,644
| +1% | +$52.8K | 0.57% | 59 |
|
|
2017
Q2 | $3.79M | Sell |
118,943
-17,045
| -13% | -$538K | 0.54% | 56 |
|
|
2017
Q1 | $4.41M | Sell |
135,988
-69,109
| -34% | -$2.18M | 0.66% | 47 |
|
|
2016
Q4 | $6.32M | Buy |
205,097
+26,202
| +15% | +$800K | 1.02% | 22 |
|
|
2016
Q3 | $5.75M | Buy |
178,895
+13,804
| +8% | +$462K | 0.98% | 24 |
|
|
2016
Q2 | $5.51M | Buy |
165,091
+14,232
| +9% | +$454K | 0.97% | 28 |
|
|
2016
Q1 | $4.24M | Buy |
150,859
+14,696
| +11% | +$420K | 0.82% | 31 |
|
|
2015
Q4 | $4.17M | Buy |
136,163
+4,388
| +3% | +$138K | 0.83% | 29 |
|
|
2015
Q3 | $3.93M | Buy |
131,775
+4,001
| +3% | +$128K | 0.94% | 27 |
|
|
2015
Q2 | $4.07M | Buy |
127,774
+8,125
| +7% | +$265K | 0.96% | 25 |
|
|
2015
Q1 | $3.95M | Buy |
119,649
+11,308
| +10% | +$360K | 0.99% | 23 |
|
|
2014
Q4 | $3.2M | Buy |
108,341
+48,904
| +82% | +$1.4M | 0.92% | 22 |
|
|
2014
Q3 | $1.67M | Buy |
59,437
+1,897
| +3% | +$53.2K | 0.48% | 84 |
|
|
2014
Q2 | $1.62M | Sell |
57,540
-8,207
| -12% | -$234K | 0.46% | 85 |
|
|
2014
Q1 | $2M | Buy |
65,747
+2,509
| +4% | +$74.8K | 0.59% | 64 |
|
|
2013
Q4 | $1.84M | Buy |
63,238
+8,622
| +16% | +$251K | 0.56% | 71 |
|
|
2013
Q3 | $1.49M | Buy |
+54,616
| New | +$1.49M | 0.49% | 85 |
|
Other funds holding PFE
Calamos Wealth Management's PFE Position: Q2 2026 in Review
Calamos Wealth Management reduced its Pfizer (PFE) stake by 3.2% in Q2 2026, selling an estimated $56.8K and leaving 65,212 shares worth $1.57M. The position accounts for 0.05% of the portfolio, ranked #166.
Calamos Wealth Management first reported a position in PFE in Q3 2013 and has held it in 52 quarters since. The position peaked at $7.24M in Q2 2019. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Calamos Wealth Management held 65,212 shares of Pfizer worth $1.57M as of Q2 2026.
- Calamos Wealth Management sold 2,171 Pfizer shares in Q2 2026, an estimated $56.8K.
- Pfizer made up 0.05% of Calamos Wealth Management's portfolio in Q2 2026, its #166 holding.
- Calamos Wealth Management first reported a position in Pfizer in Q3 2013 and has held it in 52 quarters since.
- Calamos Wealth Management's Pfizer position peaked at $7.24M in Q2 2019.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.